Combination of Multiple Serum Markers Using an Artificial Neural Network to Improve Specificity in Discriminating Malignant from Benign Pelvic Masses

This publication has 12 references indexed in Scilit:

• Understanding artificial neural networks and exploring their potential applications for the practicing urologist
  Urology, 1998
• Use of a stochastic simulation model to identify an efficient protocol for ovarian cancer screening
  Controlled Clinical Trials, 1997
• Prediction of outcome in critically ill patients using artificial neural network synthesised by genetic algorithm
  The Lancet, 1996
• Combinations of Multiple Serum Markers Are Superior to Individual Assays for Discriminating Malignant from Benign Pelvic Masses
  Gynecologic Oncology, 1995
• Artificial Neural Networks for Decision Support in Clinical Medicine
  Annals of Medicine, 1995
• Elevation of Multiple Serum Markers in Patients With Stage I Ovarian Cancer
  JNCI Journal of the National Cancer Institute, 1993
• The adnexal mass: benign or malignant? Evaluation of a risk of malignancy index
  BJOG: An International Journal of Obstetrics and Gynaecology, 1993
• How Neural Networks Learn from Experience
  Scientific American, 1992
• A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer
  BJOG: An International Journal of Obstetrics and Gynaecology, 1990
• The CA 125 tumour-associated antigen: a review of the literature
  Human Reproduction, 1989